
Bioorganic and medicinal chemistry p. 6123 - 6133,11 (2012)
Update date:2022-08-03
Topics:
Tichy, Michal
Pohl, Radek
Hocek, Michal
Xu, Hao Ying
Chen, Yen-Liang
Yokokawa, Fumiaki
Shi, Pei-Yong
A series of new pyrimido[4,5-b]indole ribonucleosides bearing phenyl or hetaryl group at position 4 has been prepared by selective Pd-catalyzed cross-coupling reactions of the corresponding protected 4,6-dichloropyrimido[4, 5-b]indole ribonucleoside with (het)arylboronic acids or stannanes followed by deprotection. Further cross-couplings under harsher conditions and employing X-Phos ligand proceeded at the position 6 leading to 4,6-disubstituted pyrimido[4,5-b]indole ribonucleosides. Some of these compounds displayed antiviral activity against Dengue virus.
View MoreHANGZHOU ZHONGCHANG SCIENTIFIC CO.,LTD
Contact:+86-571-88932183
Address:Hangzhou
jintan yufan Medicine Raw materials Co.,Ltd.(expird)
Contact:86-519-82808282
Address:6th,Jincheng Huangzhuang
shanghai jinshan pharmaceutical Co.,Ltd
Contact:021-57363011,13681638167
Address:No. 7966 Tingfeng Road,Jinshan,Shanghai,China
Hebei Tianxiang Biological & Pharmaceutical Co., Ltd
Contact:86-0312-6615158
Address:No 42 fazhan street qingyuan county
Hangzhou Showland Technology Co., Ltd.
Contact:86-571-88920516
Address:ROOM2118,NO.553,WENSAN ROAD,HANGZHOU,CHINA
Doi:10.1021/acs.orglett.1c00133
(2021)Doi:10.1021/jo01155a006
(1949)Doi:10.1007/BF00945332
()Doi:10.1021/acs.orglett.8b02701
(2018)Doi:10.1007/BF00779074
()Doi:10.1021/ja037223k
(2003)